IP Library Granted Patent US 7,455,680
Granted Patent B1
US 7,455,680 · App. 10/287,922 · Granted Nov 25, 2008

Apparatus and method for inhibiting blood loss

Assignee: Boston Scientific Scimed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,455,680
App. No.
10/287,922
Granted
Nov 25, 2008
Kind
B1
Abstract

An apparatus for inhibiting blood loss from a puncture site. The apparatus may include means for locating a puncture site in a blood vessel wall. This apparatus is comprised of a tube and an elongated member that is positioned around the tube. The elongated member includes a proximal end and a distal end. Around the tube is also a dissolvable distal capsule, the distal capsule including a proximal end and a distal end, wherein the proximal end of the distal capsule attaches to the distal end of the elongated member. Inside the distal capsule is hemostatic material such as a sponge.

Claims (42)

1. An apparatus for inhibiting blood loss from a puncture site comprising:

a tube;

an elongated member positioned around the tube, the elongated member including a proximal end and a distal end, the elongated member distal end defining an outer surface having a maximum profile dimension;

a dissolvable distal capsule positioned around the tube, the distal capsule including a proximal end and a distal end, wherein the distal capsule proximal end defines an outer surface having a maximum profile dimension substantially equal to the maximum profile dimension of the elongated member distal end outer surface, and wherein the distal capsule proximal end is bonded to the elongated member distal end at least until exposure to bodily fluid at least partially dissolves the distal capsule thereby releasing the distal capsule from the elongated member; and

hemostatic material located inside the distal capsule.

2. The apparatus according to claim 1 , wherein the distal end of the dissolvable distal capsule is rounded.

3. The apparatus according to claim 1 , wherein the distal capsule is made of an absorbable material.

4. The apparatus according to claim 1 , wherein the distal capsule is made of a biocompatible material.

5. The apparatus according to claim 1 , wherein the distal capsule is made of a gelatin film.

6. The apparatus according to claim 1 , wherein the distal end of the elongated member has a substantially concave spherical shape.

7. The apparatus according to claim 1 , further comprising a control tip assembly.

8. The apparatus according to claim 7 , wherein the control tip assembly has a proximal end portion, a distal end portion having a distal port, and a central portion between the proximal end portion and the distal end portion, the control tip including a lumen.

9. The apparatus according to claim 8 , wherein the control tip proximal end portion is externally tapered.

10. The apparatus according to claim 8 , wherein the control tip distal end portion is externally tapered.

11. The apparatus according to claim 8 , wherein the control tip further comprises a hole extending laterally through the central portion and connecting the control tip lumen with the exterior of the central portion.

12. The apparatus according to claim 8 , wherein the control tip lumen has a substantially constant inner diameter.

13. The apparatus according to claim 8 , wherein the control tip lumen has an inner diameter larger in the central portion than in the distal portion.

14. An apparatus for inhibiting blood loss from a puncture site comprising:

a tube;

an elongated member positioned around the tube, the elongated member including a proximal end and a distal end;

a dissolvable distal capsule positioned around the tube, the distal capsule including a proximal end and a distal end, wherein the proximal end of the distal capsule attaches to the distal end of the elongated member and the distal end of the elongated member has an outer diameter which is slightly smaller than an outer diameter of the elongated member for accepting the dissolvable distal capsule; and

hemostatic material located inside the distal capsule.

15. An apparatus for inhibiting blood loss from a puncture site comprising:

an elongated member having a lumen for receiving a guidewire, the elongated member including a proximal end and a distal end, the elongated member distal end defining an outer surface having a maximum profile dimension;

a dissolvable distal capsule positioned around the lumen, the distal capsule including a proximal end and a distal end, wherein the distal capsule proximal end defines an outer surface having a maximum profile dimension substantially equal to the maximum profile dimension of the elongated member distal end outer surface, and wherein the distal capsule proximal end is bonded to the elongated member distal end at least until exposure to bodily fluid at least partially dissolves the distal capsule thereby releasing the distal capsule from the elongated member; and

hemostatic material located inside the distal capsule.

16. The apparatus according to claim 15 , wherein the distal end of the dissolvable distal capsule is rounded.

17. The apparatus according to claim 15 , wherein the distal capsule is made of an absorbable material.

18. The apparatus according to claim 15 , wherein the distal capsule is made of a biocompatible material.

19. The apparatus according to claim 15 , wherein the distal capsule is made of a gelatin film.

20. The apparatus according to claim 15 , wherein the distal end of the elongated member has a substantially concave spherical shape.

21. The apparatus according to claim 15 , further comprising a control tip assembly.

22. The apparatus according to claim 21 , wherein the control tip assembly has a proximal end portion, a distal end portion having a distal port, and a central portion between the proximal end portion and the distal end portion, the control tip including a lumen extending from the distal port.

23. The apparatus according to claim 22 , wherein the control tip further comprises a hole extending laterally through the central portion and connecting the control tip lumen with the exterior of the central portion.

24. An apparatus for inhibiting blood loss from a puncture site comprising:

an elongated member having a lumen for receiving a guidewire, the elongated member including a proximal end and a distal end;

a dissolvable distal capsule positioned around the lumen, the distal capsule including a proximal end and a distal end, wherein the proximal end of the distal capsule attaches to the distal end of the elongated member and the distal end of the elongated member has an outer diameter which is slightly smaller than an outer diameter of the elongated member for accepting the dissolvable distal capsule; and

hemostatic material located inside the distal capsule.

25. A system for locating a puncture site in a blood vessel wall and for inhibiting blood loss from the puncture site comprising:

hemostatic material delivery system having a tube;

an elongated member positioned around the tube and having a distal end defining an outer surface having a maximum profile dimension, a dissolvable distal capsule positioned around the tube and having a proximal end defining an outer surface having a maximum profile dimension substantially equal to the maximum profile dimension of the elongated member distal end outer surface, the distal capsule proximal end being bonded to the elongated member distal end at least until exposure to bodily fluid at least partially dissolves the distal capsule thereby releasing the distal capsule from the elongated member, and hemostatic material located inside the distal capsule; and

a control tip assembly having a control tip and a control tip body.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2006
From: SUB-Q, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018420/0029 →
NOTE AND WARRANT PURCHASE AGREEMENT Recorded Sep 21, 2004
From: SUB-Q, INC.
To: BOSTON SCIENTIFIC CORPORATION; PACIFIC VENTURE GROUP II, L.P.; PVG ASSOCIATES II, L.P.; PEQUOT PRIVATE EQUITY FUND II, L.P.; KINGSBURY CAPITAL PARTNERS, L.P. III; KINGSBURY CAPITAL PARTNERS, L.P. IV; HARTZLER, GEOFFREY O.; WALLACE, GEORGE; CRAGG, ANDREW H.; ALLEN FAMILY TRUST DATED 10/12/81; FEUCHTER, BRUCE
Reel/Frame 015156/0484 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2003
From: ASHBY, MARK; TRAN, TIN
To: SUB-Q, INC.
Reel/Frame 013734/0810 →